Due: October 4, 2024 This FOA would support establishing deeper mechanistic insight and causal relationships between TDP-43 pathology and phenotypic outcomes, as well as mechanistic interactions between TDP-43 and other co-pathologies, such TMEM106B. Additionally, it Read More
Deadline: November 1, 2024 Heat stress poses a considerable risk to workers across various industries and organizations. Exposure to extreme heat can not only lead to an array of illnesses and injuries, but can also Read More
Anticipated Release Date: Q3FY25 PPTS-ENBD will provide a biocontainment isolation system to safely transport personnel infected or suspected of infection from a biological threat. Responding to this opportunity requires membership in the Countering Weapons of Read More
Due: October 11, 2024 Chemical Biological Center, Research and Technology Directorate, Sensor Technologies and BioMaterials Division, Spectroscopy Branch is seeking a solution for sensitive and selective detection of hazardous vapors. To develop a handheld, battery-operated, Read More
Due: October 4, 2024 This solicitation is issued by the MCDC Consortium Manager (CM), Advanced Technology International (ATI), represents a Request for Project Proposals (RPP) for the 2024 “MCDC Commercialization Grant” mechanism. Responding to this Read More
Due: October 4, 2024 This solicitation is issued by the CWMD Consortium Manager (CM), Advanced Technology International (ATI), represents a Request for Project Proposals (RPP) for the 2024 “CWMD Commercialization Grant” mechanism. Responding to this Read More
Anticipated Release Date: Q1FY25 FDA approval of a multi-drug autoinjector to reduce logistical burden on the warfighter and increase survivability. Responding to this opportunity requires membership in the Medical CBRN Defense Consortium. This Consortium releases numerous Read More
Anticipated Release Date: Q3FY25 SIS will provide the capability to temporarily isolate or quarantine personnel to prevent the spread of a biological threat and safely evacuate patients for transfer off the ship. Capability will contain Read More
Anticipated Release Date: Q3FY26 ASPIRE will provide respiratory and ocular protection against Chemical, Biological, Radiological and Nuclear threats that allows near normal operations by minimizing or eliminating physical and psychological burden and increasing Warfighter lethality. Read More
Due: March 13, 2025 The scientific objective of this Funding Opportunity Announcement is to encourage research to delineate the role of inflammasomes in the neuropathology produced by acute or chronic drug exposure and HIV infection. Read More
NTA is operated by the 501c(3) non-profit Advanced Technology International (ATI). National Technology Alliance (NTA) © 2024 - All rights reserved.